Frankfurt - Delayed Quote EUR
Incyte Corporation (ICY.F)
50.88
+0.12
+(0.24%)
As of 8:04:42 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 19 | 17 | 23 | 21 |
| Avg. Estimate | 994.92M | 1.15B | 4.67B | 5.14B |
| Low Estimate | 918.51M | 1.1B | 4.58B | 4.87B |
| High Estimate | 1.1B | 1.2B | 4.81B | 5.51B |
| Year Ago Sales | 880.89M | 1.04B | 4.24B | 4.67B |
| Sales Growth (year/est) | 12.94% | 10.24% | 10.01% | 10.10% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ICY.F | -- | -- | -- | -- |
| S&P 500 | 6.85% | 4.67% | 8.41% | 14.16% |
Upgrades & Downgrades
| Maintains | JP Morgan: Neutral to Neutral | 4/21/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 3/24/2025 |
| Maintains | Truist Securities: Hold to Hold | 3/18/2025 |
| Downgrade | Guggenheim: Buy to Neutral | 3/18/2025 |
| Downgrade | William Blair: Outperform to Market Perform | 3/18/2025 |
| Reiterates | Citizens Capital Markets: Market Perform to Market Perform | 3/11/2025 |
Related Tickers
1VRTX.MI Vertex Pharmaceuticals Incorporated
438.15
+1.62%
SABS SAB Biotherapeutics, Inc.
1.3700
+3.79%
PRLD Prelude Therapeutics Incorporated
0.8832
-5.91%
CTXR Citius Pharmaceuticals, Inc.
0.8420
+2.67%
CCCC C4 Therapeutics, Inc.
1.6100
+3.21%
VRTX Vertex Pharmaceuticals Incorporated
492.42
+0.40%
PSTV Plus Therapeutics, Inc.
0.9835
+24.97%
VERV Verve Therapeutics, Inc.
5.47
+4.19%
IOVA Iovance Biotherapeutics, Inc.
3.1900
-0.62%
CRSP CRISPR Therapeutics AG
38.54
-1.76%